CORE
CO
nnecting
RE
positories
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Research partnership
About
About
About us
Our mission
Team
Blog
FAQs
Contact us
Community governance
Governance
Advisory Board
Board of supporters
Research network
Innovations
Our research
Labs
Filters
3 research outputs found
Comparison of treatment patterns and economic outcomes in metastatic breast cancer patients initiated on trastuzumab versus lapatinib: a retrospective analysis
Author
A Borg
A Elixhauser
+19 more
AJ Montero
CT Guy
DJ Slamon
DJ Slamon
DJ Slamon
G Gullo
Genentech Inc.
Genentech Inc.
Genentech Inc.
GlaxoSmithKline LLC
H Quan
M Mayer
M Vera-Llonch
National Comprehensive Cancer Network
PharMetrics
PJ Medina
R Siegel
Susan G Komen Foundation
V Kumar
Publication venue
'Springer Science and Business Media LLC'
Publication date
Field of study
Get PDF
Crossref
Antirheumatic drug use and the risk of acute myocardial infarction
Author
Bombardier
Bresalier
+33 more
Cauza
Choi
Davis
Del Rincon
Del Rincon
Doggen
Gabriel
Garcia Rodriguez
Graham
Jacobsson
Kimmel
Konstam
Levesque
Mamdani
Maradit-Kremers
Mukherjee
Munro
Pharmetrics Inc.
Rahme
Ray
Ray
Rohde
Rozman
Sholter
Solomon
Solomon
Solomon
Solomon
Suissa
Suissa
Thal
Watson
Wolfe
Publication venue
'Wiley'
Publication date
01/01/2006
Field of study
No full text
Crossref
Use of cyclo-oxygenase 2 inhibitors (COX-2) and prescription non-steroidal anti-inflammatory drugs (NSAIDS) in UK and USA populations. Implications for COX-2 cardiovascular profile
Author
Bennett
Bombardier
+43 more
Bresalier
Chan
Congestive Heart Failure
Dai
Dominick
Drazen
Florentinus
García Rodríguez
García- Rodríguez
García-Rodríguez
Graham
Helin-Salmivaara
Henry
Hernández-Díaz
Hernández-Díaz
Hippisley-Cox
Johansson
Johnsen
Jüni
Kimmel
Krum
Levesque
Levy
MacDonald
Mamdami
Mamdani
Mamdani
Merck Announces Voluntary Worldwide Withdrawal of VIOXX®.
Moride
National Institute for Clinical Excellence (NICE)
Nussmeier
Ofman
Page
PharMetrics
Ray
Shaya
Solomon
Solomon
The Health Improvement Network (THIN)
Ulcickas Yood
Velentgas
Von Korff
Wolfe
Publication venue
'Wiley'
Publication date
01/01/2006
Field of study
No full text
Crossref